The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial
Open accessAbstract
BACKGROUND: Undiagnosed tuberculosis (TB) remains the most common cause of HIV-related mortality. Xpert MTB/RIF (Xpert) is being rolled out globally to improve TB diagnostic capacity. However, previous Xpert impact trials have reported that health system weaknesses blunted impact of this improved diagnostic tool. During phased Xpert rollout in Botswana, we evaluated the impact of a package of interventions comprising (1) additional support for intensified TB case finding (ICF), (2) active tracing for patients missing clinic appointments to support retention, and (3) Xpert replacing sputum-smear microscopy, on early (6-month) antiretroviral therapy (ART) mortality. METHODS: At 22 clinics, ART enrollees > 12 years old were eligible for inclusion in three phases: a retrospective standard of care (SOC), prospective enhanced care (EC), and prospective EC plus Xpert (EC+X) phase. EC and EC+X phases were implemented as a stepped-wedge trial. Participants in the EC phase received SOC plus components 1 (strengthened ICF) and 2 (active tracing) of the intervention package, and participants in the EC+X phase received SOC plus all three intervention package components. Primary and secondary objectives were to compare all-cause 6-month ART mortality between SOC and EC+X and between EC and EC+X phases, respectively. We used adjusted analyses, appropriate for study design, to control for baseline differences in individual-level factors and intra-facility correlation. RESULTS: We enrolled 14,963 eligible patients: 8980 in SOC, 1768 in EC, and 4215 in EC+X phases. Median age of ART enrollees was 35 and 64% were female. Median CD4 cell count was lower in SOC than subsequent phases (184/μL in SOC, 246/μL in EC, and 241/μL in EC+X). By 6 months of ART, 461 (5.3%) of SOC, 54 (3.2%) of EC, and 121 (3.0%) of EC+X enrollees had died. Compared with SOC, 6-month mortality was lower in the EC+X phase (adjusted hazard ratio, 0.77; 95% confidence interval, 0.61-0.97, p = 0.029). Compared with EC enrollees, 6-month mortality was similar among EC+X enrollees. CONCLUSIONS: Interventions to strengthen ICF and retention were associated with lower early ART mortality. This new evidence highlights the need to strengthen ICF and retention in many similar settings. Similar to other trials, no additional mortality benefit of replacing sputum-smear microscopy with Xpert was observed. TRIAL REGISTRATION: Retrospectively registered: ClinicalTrials.gov (NCT02538952).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Health facilities, strategically chosen as clusters in numerous studies, underscore the emphasis on healthcare delivery and interventions within controlled environments.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The everyday use of hospitals and clinics as clusters is rooted in their pivotal role in healthcare delivery, enabling the implementation and evaluation of interventions to enhance patient outcomes (26, 27, 30–34, 36–47, 49, 50, 52–71, 73–75, 77–81, 83–89, 91–96, 98–102, 104, 105, 107, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting
Hemming, K., Haines, T. P., Chilton, P. J., Girling, A. J., & Lilford, R. J. (2015) · BMJ · doi:10.1136/bmj.h391 · Cited by 1,410 · cited 1×
“The first sensitivity analysis censors follow-up time for ART enrollees at the time of cross-over between phases, while the second assigns follow-up time to contemporary intervention phases when cross-over occurs, through use of a time-dependent covariate [18].”
BackgroundBrinkhof, M. W. G., Pujades-Rodriguez, M., & Egger, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005790 · Cited by 482
Johnson, L. F., Mossong, J., Dorrington, R. E., Schomaker, M., Hoffmann, C. J., Keiser, O., Fox, M. P., Wood, R., Prozesky, H., Giddy, J., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001418 · Cited by 437
Theron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., Bara, W., Mungofa, S., Pai, M., Hoelscher, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62073-5 · Cited by 433
Getahun, H., Kittikraisak, W., Heilig, C. M., Corbett, E. L., Ayles, H., Cain, K. P., Grant, A. D., Churchyard, G. J., Kimerling, M., Shah, S., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000391 · Cited by 404
Gupta, R. K., Lucas, S. B., Fielding, K. L., & Lawn, S. D. (2015) · AIDS · doi:10.1097/qad.0000000000000802 · Cited by 371 · cited 1×
“therapy (ART), and is commonly undiagnosed at the time of death [1, 2].”
BackgroundAlbert, H., Nathavitharana, R. R., Isaacs, C., Pai, M., Denkinger, C. M., & Boehme, C. C. (2016) · European Respiratory Journal · doi:10.1183/13993003.00543-2016 · Cited by 300
Gupta, A., Nadkarni, G., Yang, W.-T., Chandrasekhar, A., Gupte, N., Bisson, G. P., Hosseinipour, M., & Gummadi, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028691 · Cited by 254
May, M., Boulle, A., Phiri, S., Messou, E., Myer, L., Wood, R., Keiser, O., Sterne, J. A., Dabis, F., & Egger, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60666-6 · Cited by 250
Research works printed but not linked: 1
- Agizew T, Nyirenda S, Mathoma A, Mathebula U, Date A, Kgwaadira B, et al. Comparison of pre- and post-Xpert tuberculosis treatment outcomes among people living with HIV in Botswana. (Abstract # PC-1124-06). 46th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease. Cape Town, 2–6 December 2015. Available at: https://theunion.org/what-we-do/journals/ijtld/body/Abstract_Book_2015-Web.pdf. Accessed 30 Nov 2019.
Cited by
Shapiro, A. E., Ross, J. M., Yao, M., Schiller, I., Kohli, M., Dendukuri, N., Steingart, K. R., & Horne, D. J. D. L. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013694.pub2 · Cited by 83
“…2019 no microbiological reference standard (TB culture) Auld 2016a not original research Auld 2016b persons not screened irrespective of symptoms Auld 2020 no microbiological reference standard (TB culture) Awan 2018 persons not screened irrespective of symptoms Ayala 2016 persons not…”
BackgroundMeasures of Retention in HIV Care: A Study Within a Review
Rehman, N., Wu, M., Garcia, C., Leenus, A., El-Kechen, H., Bhandari, M., Zakaryan, G., Zani, B., Hajizadeh, A., Wang, A. R., et al. (2023) · AIDS Patient Care and STDs · doi:10.1089/apc.2022.0225 · Cited by 12
Auld, A. F., Kerkhoff, A. D., Hanifa, Y., Wood, R., Charalambous, S., Liu, Y., Agizew, T., Mathoma, A., Boyd, R., Date, A. A., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003739 · Cited by 11
“We implemented intensive efforts to ascertain true active TB disease among participants with TB case finding procedures previously published and provided in a Supporting information appendix (S1 Text) [15,16].”
InfluentialSalomon, A., Law, S. J., Johnson, C., Baddeley, A., Rangaraj, A., Singh, S., & Daftary, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267511 · Cited by 10
Auld, A. F., Fielding, K., Agizew, T., Maida, A., Mathoma, A., Boyd, R., Date, A. A., Pals, S. L., Bicego, G. T., Liu, Y., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01775-8 · Cited by 5
Metadata
- Authors
- Auld, A. F., Agizew, T., Mathoma, A., Boyd, R., Date, A., Pals, S. L., Serumola, C., Mathebula, U., Alexander, H., Ellerbrock, T. V., Rankgoane-Pono, G., Pono, P., Shepherd, J. C., Fielding, K., Grant, A. D., & Finlay, A.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Centers for Disease Control and Prevention (UG)
- Ministry of Health (BW)
- Yale University (US)
- University of the Witwatersrand (ZA)
- Corresponding author
- Auld, Andrew F.
- ORCID
- Venue
- BMC Medicine
- Published
- 2020-02-11
- Volume
- 18
- Issue
- 1
- Pages
- 19-19
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC7011529
- OpenAlex
- W3012641266
- Cited by
- 14
- References
- 32
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 7
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. President’s Emergency Plan for AIDS Relief (Not applicable.)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculosis screening, Xpert MTB/RIF, sputum smear microscopy, HIV/TB coinfection, patient retention, missed appointments, Botswana, health system capacity, CD4 count, stepped-wedge cluster randomized trial
- MeSH terms
- Adult, Botswana, Female, Humans, Male, Mass Screening, Mycobacterium tuberculosis, Prospective Studies, Tuberculosis, Survival Analysis, Anti-Retroviral Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial. https://app.cochat.ai/papers/10.1186/s12916-019-1489-0
- The paper
- Auld, A. F., Agizew, T., Mathoma, A., Boyd, R., Date, A., Pals, S. L., Serumola, C., Mathebula, U., Alexander, H., Ellerbrock, T. V., Rankgoane-Pono, G., Pono, P., Shepherd, J. C., Fielding, K., Grant, A. D., & Finlay, A. (2020). Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial. BMC Medicine. https://doi.org/10.1186/s12916-019-1489-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.